QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
NASDAQ:AFIB

Acutus Medical - AFIB Stock Forecast, Price & News

$0.81
+0.01 (+1.25%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.80
▼
$0.84
50-Day Range
$0.80
▼
$1.87
52-Week Range
$0.48
▼
$2.15
Volume
37,675 shs
Average Volume
182,535 shs
Market Capitalization
$23.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Acutus Medical MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
147.0% Upside
$2.00 Price Target
Short Interest
Healthy
1.84% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.22mentions of Acutus Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.39) to ($1.68) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

468th out of 986 stocks

Surgical & Medical Instruments Industry

46th out of 100 stocks

See Top Rated MarketRank™ Stocks Here

AFIB stock logo

About Acutus Medical (NASDAQ:AFIB) Stock

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

March 22, 2023 | markets.businessinsider.com
BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)
March 18, 2023 | markets.businessinsider.com
BTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)
March 23, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
March 18, 2023 | finance.yahoo.com
Acutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call Transcript
March 16, 2023 | msn.com
Acutus Medical GAAP EPS of $0.41 beats by $1.12, revenue of $5M beats by $0.45M
March 16, 2023 | finance.yahoo.com
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
March 16, 2023 | finance.yahoo.com
Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates
March 16, 2023 | marketwatch.com
Afib Heart Devices Market [2023-2028] | Latest Study on Global Industry Trends & Future Forecast
March 23, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
March 15, 2023 | benzinga.com
Acutus Medical's Earnings: A Preview
March 15, 2023 | americanbankingnews.com
Acutus Medical (AFIB) Scheduled to Post Earnings on Thursday
March 9, 2023 | finance.yahoo.com
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
February 20, 2023 | msn.com
Medical Moment: Amulet for AFib
February 18, 2023 | msn.com
Common symptoms of atrial fibrillation as per experts
February 17, 2023 | msn.com
American Heart Month: 7 things to know about AFib
February 2, 2023 | technews.tmcnet.com
Volta Medical Announces Completion of Patient Enrollment in TAILORED-AF Clinical Trial for Treatment of Atrial Fibrillation
February 2, 2023 | finance.yahoo.com
Acutus Medical (NASDAQ:AFIB) shareholders are up 14% this past week, but still in the red over the last year
January 31, 2023 | benzinga.com
Global Electrophysiology Devices Market Is Expected To Increase to US$ 20.80 Billion by 2033-End: Fact.MR Analysis
January 18, 2023 | seekingalpha.com
Acutus Medical Focuses On Existing Customer Base As Revenue Growth Falters
January 9, 2023 | markets.businessinsider.com
Acutus Medical Sees Q4, FY22 Revenues Well Above Estimates; Appoints Takeo Mukai As CFO
January 9, 2023 | finance.yahoo.com
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
December 29, 2022 | finance.yahoo.com
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
December 21, 2022 | benzinga.com
Looking Into Acutus Medical's Return On Capital Employed
December 21, 2022 | finance.yahoo.com
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
December 19, 2022 | finance.yahoo.com
Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
December 6, 2022 | finance.yahoo.com
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
November 12, 2022 | finance.yahoo.com
Acutus Medical Third Quarter 2022 Earnings: EPS Beats Expectations
See More Headlines
Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Company Calendar

Last Earnings
11/11/2021
Today
3/23/2023
Next Earnings (Estimated)
5/11/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AFIB
CUSIP
N/A
CIK
1522860
Web
www.acutusmedical.com
Phone
442-232-6080
Fax
442-232-6081
Employees
291
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+147.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.57)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-39,620,000.00
Net Margins
-242.11%
Pretax Margin
-545.51%
Return on Equity
-45.94%
Return on Assets
-24.27%

Debt

Debt-to-Equity Ratio
0.59
Current Ratio
5.12
Quick Ratio
4.33

Sales & Book Value

Annual Sales
$16.36 million
Price / Sales
1.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.78 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
28,450,000
Free Float
21,538,000
Market Cap
$23.04 million
Optionable
Not Optionable
Beta
0.95

Social Links


Key Executives

  • Mr. R. Scott Huennekens CPA (Age 58)
    M.B.A., Exec. Chairman
    Comp: $121k
  • Mr. David Harrison Roman (Age 40)
    CEO, Pres & Director
    Comp: $679.4k
  • Mr. Vincent J. Burgess (Age 57)
    Consultant
    Comp: $583.5k
  • Mr. Takeo Mukai
    VP of Fin. & Accounting and Interim CFO
  • Dr. Graydon E. Beatty (Age 65)
    Chief Technology Officer
  • Dr. Derrick Chou Ph.D.
    Chief Technology Officer
  • Mr. Tom Sohn (Age 47)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Shibaji Shome Ph.D.
    VP of Marketing
  • Mr. Charlie Piscitello (Age 59)
    Sr. VP & Chief People Officer
  • Mr. Gary W. Doherty (Age 56)
    Sr. VP of Fin.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













AFIB Stock - Frequently Asked Questions

Should I buy or sell Acutus Medical stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" AFIB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFIB, but not buy additional shares or sell existing shares.
View AFIB analyst ratings or view top-rated stocks.

What is Acutus Medical's stock price forecast for 2023?

3 brokers have issued 12 month price targets for Acutus Medical's stock. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they expect the company's stock price to reach $2.00 in the next year. This suggests a possible upside of 147.0% from the stock's current price.
View analysts price targets for AFIB or view top-rated stocks among Wall Street analysts.

How have AFIB shares performed in 2023?

Acutus Medical's stock was trading at $1.15 at the beginning of 2023. Since then, AFIB stock has decreased by 29.6% and is now trading at $0.8098.
View the best growth stocks for 2023 here.

When is Acutus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our AFIB earnings forecast.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) posted its earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.92) by $0.02. The company had revenue of $4.60 million for the quarter, compared to the consensus estimate of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 45.94% and a negative net margin of 242.11%. During the same quarter last year, the business posted ($1.18) EPS.

What guidance has Acutus Medical issued on next quarter's earnings?

Acutus Medical issued an update on its FY 2023 earnings guidance on Thursday, March, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $18.00 million-$21.00 million, compared to the consensus revenue estimate of $20.46 million.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

When did Acutus Medical IPO?

(AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Acutus Medical's stock symbol?

Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."

Who are Acutus Medical's major shareholders?

Acutus Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (1.07%), Kamunting Street Capital Management L.P. (0.91%), Millennium Management LLC (0.63%), Morgan Stanley (0.45%), Nicolet Advisory Services LLC (0.10%) and Belvedere Trading LLC (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens.
View institutional ownership trends.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acutus Medical's stock price today?

One share of AFIB stock can currently be purchased for approximately $0.81.

How much money does Acutus Medical make?

Acutus Medical (NASDAQ:AFIB) has a market capitalization of $23.04 million and generates $16.36 million in revenue each year. The company earns $-39,620,000.00 in net income (profit) each year or ($1.57) on an earnings per share basis.

How many employees does Acutus Medical have?

The company employs 291 workers across the globe.

Does Acutus Medical have any subsidiaries?
The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..
Read More
How can I contact Acutus Medical?

Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081.

This page (NASDAQ:AFIB) was last updated on 3/23/2023 by MarketBeat.com Staff